TGI
TRV GP IV Portfolio holdings
AUM
$163M
This Quarter Return
+25.64%
1 Year Return
-8.31%
3 Year Return
+262.88%
5 Year Return
+149.36%
10 Year Return
–
AUM
$441M
AUM Growth
+$441M
(+110%)
Cap. Flow
+$241M
Cap. Flow
% of AUM
54.74%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
1
Increased
–
Reduced
1
Closed
–
Top Buys
| 1 |
Tango Therapeutics
TNGX
|
$250M |
Top Sells
| 1 |
Dianthus Therapeutics
DNTH
|
$9.1M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Tango Therapeutics
TNGX
$747M
| $250M | 56.81% |
+19,363,975
| New | +$250M |
|
2
Fulcrum Therapeutics
FULC
$351M
| $66.1M | 15% |
2,343,154
| – | – |
|
|
3
Dianthus Therapeutics
DNTH
$759M
| $49.2M | 11.16% |
6,758,204
-1,250,000
| -16% | -$9.1M |
|
4
Revolution Medicines
RVMD
$7.1B
| $39.1M | 8.86% |
1,419,900
| – | – |
|
5
Pliant Therapeutics
PLRX
$101M
| $36M | 8.17% |
2,132,867
| – | – |
|